DMIC
GSK icon

Dixon Mitchell Investment Counsel’s GSK GSK Stock Holding History

Dixon Mitchell Investment Counsel’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-32,066
Closed -$1.67M – 66
2015
Q2 		$1.67M Sell
32,066
-606
-2% -$34.1K 0.26% 60
2015
Q1 		$1.88M Sell
32,672
-3,712
-10% -$213K 0.29% 57
2014
Q4 		$2.09M Hold
36,384
– – 0.32% 53
2014
Q3 		$2.09M Sell
36,384
-812
-2% -$49.8K 0.32% 54
2014
Q2 		$2.49M Sell
37,196
-496
-1% -$33.6K 0.36% 54
2014
Q1 		$2.52M Buy
37,692
+240
+0.6% +$16.2K 0.4% 53
2013
Q4 		$2.5M Buy
37,452
+936
+3% +$60.7K 0.4% 48
2013
Q3 		$2.29M Sell
36,516
-1,304
-3% -$83.9K 0.39% 46
2013
Q2 		$2.36M Buy
+37,820
New +$2.4M 0.44% 39

Other funds holding GSK

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Dixon Mitchell Investment Counsel's GSK Position: Q3 2015 in Review

Dixon Mitchell Investment Counsel sold out of GSK (GSK) in Q3 2015, closing a stake of 32,066 shares — an estimated $1.67M sold.

Dixon Mitchell Investment Counsel first reported a position in GSK in Q2 2013 and held it in 9 quarters. The position peaked at $2.52M in Q1 2014. 706 funds tracked by Wall St. Rank hold GSK as of Q3 2015.

  • Dixon Mitchell Investment Counsel reported no remaining GSK position as of Q3 2015 after selling out during the quarter.
  • Dixon Mitchell Investment Counsel sold 32,066 GSK shares in Q3 2015, an estimated $1.67M.
  • Dixon Mitchell Investment Counsel first reported a position in GSK in Q2 2013 and held it in 9 quarters.
  • Dixon Mitchell Investment Counsel's GSK position peaked at $2.52M in Q1 2014.
  • 706 funds tracked by Wall St. Rank held GSK as of Q3 2015.

Based on Dixon Mitchell Investment Counsel's 13F filing for Q3 2015, filed 17 Jan 2024.